You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 10, October 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Multiple Endocrine Neoplasm, Type 1

Gastrinomas, Pancreatic Neoplasms, Microcarcinoids, the Zollinger-Ellison Syndrome, Lymph Nodes, and Hepatic Metastases

Joseph J. Shepherd, MD; David R. Challis, FRCPA; Peter F. Davies, FRACR; John P. McArdle, FRCPA; Bin T. Teh, MBBS; Steven Wilkinson, FRACS

Arch Surg. 1993;128(10):1133-1142.


Abstract

Objective
We reviewed the age of presentation, malignant potential, and outcome of gastrinomas and pancreatic tumors in patients with multiple endocrine neoplasm, type 1.

Design
Screening of one very large and one smaller, possibly related family on an island, including serum gastrin estimations and, when indicated, pancreatic ultrasound.

Setting and Patients
Over 2000 family members and their family physicians were advised on screening procedures.

Intervention
Data were collected and reviewed retrospectively and prospectively for all medical records, investigations, surgical procedures, and available tissue samples.

Outcome Measurements
Criteria for diagnosis were established for radiological, biochemical, and histological studies.

Results
Sixty-two patients had evidence of gastrinoma or pancreatic neoplasm. In 19 patients the diagnosis was based on demonstration of a tumor. In 21 patients the diagnosis was based on elevated serum gastrin concentration in the absence of demonstrable tumor. None of these patients required gastric surgery if they first underwent parathyroidectomy. In 18 patients the diagnosis was based on the combination of demonstrated pancreatic tumor plus elevated glucagon (two patients), gastrin (11 patients), or insulin (five patients) concentration. Peptic ulcer was difficult to control in seven of the 11 patients with elevated gastrin concentrations plus demonstrated tumor. Four patients had liver metastases that appeared to be secondary to the pancreatic gastrinoma. In patients with insulinomas, the first symptoms occurred before age 20 years. Elevated serum gastrin concentrations were not seen before age 24 years and were observed to occur for the first time in two patients after age 50 years.

(Arch Surg. 1993;128:1133-1142)



Author Affiliations

From the Department of Surgery, University of Tasmania, Hobart (Drs Shepherd, Teh, and Wilkinson), and the Departments of Pathology (Drs Challis and McArdle) and Radiology (Dr Davies), Royal Hobart Hospital, Tasmania, Australia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Zollinger-Ellison Syndrome: Advances in Treatment of Gastric Hypersecretion and the Gastrinoma
Jensen and Fraker
JAMA 1994;271:1429-1435.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.